CliffBio
small molecule

TRELSTAR

TRIPTORELIN PAMOATE

Loss of exclusivityJune 2029latest FDA-listed patent expiry
CompanyVerity Pharmaceuticals →View the full company profile on CliffBio

Drug detail

Brand nameTRELSTAR
Active ingredientTRIPTORELIN PAMOATE
StrengthEQ 22.5MG BASE/VIAL
Dosage formINJECTABLE
RouteINTRAMUSCULAR
ModalitySmall molecule
FDA approvalMarch 2010
Marketing statusRX

Listed patents

PatentExpiresType
10166181June 2029product

More from Verity Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

TRELSTAR patent cliff — loss of exclusivity June 2029 | CliffBio